English  |  正體中文  |  简体中文  |  2817371  
???header.visitor??? :  27722096    ???header.onlineuser??? :  572
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"piratvisuth t"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 26-32 of 32  (2 Page(s) Totally)
<< < 1 2 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2018-09-10T15:24:49Z Reimbursement policies in the Asia-Pacific for chronic hepatitis B Lim, S.G.;Amarapurkar, D.N.;Chan, H.L.-Y.;Crawford, D.H.;Gane, E.J.;Han, K.-H.;Ahn, S.H.;Jafri, W.;Jia, J.;Kao, J.-H.;Lesmana, L.A.;Lesmana, C.R.A.;Mohamed, R.;Phiet, P.H.;Piratvisuth, T.;Sarin, S.K.;Sollarno, J.D.;Eguchi, Y.;Mahtab, M.-A.;Lee, K.H.; JIA-HORNG KAO
臺大學術典藏 2018-09-10T08:16:50Z Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed? Sung, J.J.Y.;Amarapurkar, D.;Chan, H.L.Y.;Cheng, J.;Kao, J.-H.;Han, K.-H.;Piratvisuth, T.; JIA-HORNG KAO
臺大學術典藏 2018-09-10T08:16:48Z Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy Lui, Y.Y.-N.;Tsoi, K.K.-F.;Wong, V.W.-S.;Kao, J.-H.;Hou, J.-L.;Teo, E.-K.;Mohamed, R.;Piratvisuth, T.;Han, K.-H.;Mihm, U.;Wong, G.L.-H.;Chan, H.L.-Y.; JIA-HORNG KAO
臺大學術典藏 2018-09-10T05:25:11Z Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2005 update Liaw, Y.-F.; Leung, N.; Guan, R.; Lau, G.K.K.; Merican, I.; Mccaughan, G.; Gane, E.; Kao, J.-H.; Omata, M.; Chutaputti, B.A.; Chen, D.S.; Chien, R.N.; Cooksley, G.; Han, K.H.; Ichida, T.; Lai, M.Y.; Lesmana, L.; Piratvisuth, T.; Sarin, S.K.; Sollano, J.; Suh, D.J.; Yao, G.B.; Yeh, C.T.; Yokosuka, O.; DING-SHINN CHEN; JIA-HORNG KAO
國立臺灣大學 2016 Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update Sarin, S. K.; Kumar, M.; Lau, G. K.; Abbas, Z.; Chan, H. L. Y.; Chen, C. J.; Chen, D. S.; Chen, H. L.; Chen, P. J.; Chien, R. N.; Dokmeci, A. K.; Gane, Ed; Hou, J. L.; Jafri, W.; Jia, J.; Kim, J. H.; Lai, C. L.; Lee, H. C.; Lim, S. G.; Liu, C. J.; Locarnini, S.; Al Mahtab, M.; Mohamed, R.; Omata, M.; Park, J.; Piratvisuth, T.; Sharma, B. C.; Sollano, J.; Wang, F. S.; Wei, L.; Yuen, M. F.; Zheng, S. S.; Kao, J. H.; 陳定信; 高嘉宏; 劉俊人; 陳培哲
高雄醫學大學 2013 Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.  GR*, Foster;Zeuzem, S;Pianko, S;Sarin, SK;Piratvisuth, T;Shah, S;Andreone, P;Sood, A;莊萬龍;Lee, CM;George, J;Gould, M;Flisiak, R;Jacobson, IM;Komolmit, P;Thongsawat, S;Tanwandee, T;Rasenack, J;Sola, R;Messina, I;Yin, Y;Cammarata, S;Feutren, G;Brown, KK. ; Foster, GR;Zeuzem, S;Pianko, S;Sarin, SK;Piratvisuth, T;Shah, S;Andreone, P;Sood, A;Chuang, WL;Lee, CM;George, J;Gould, M;Flisiak, R;Jacobson, IM;Komolmit, P;Thongsawat, S;Tanwandee, T;Rasenack, J;Sola, R;Messina, I;Yin, Y;Cammarata, S;Feutren, G;Brown, KK. 
高雄醫學大學 2011 Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C.  廖運範(長庚)莊萬龍; Liaw YF;Jia JD;Chan HL;Han KH;Tanwandee T;Chuang WL;Tan DM;Chen XY;Gane E;Piratvisuth T;Chen L;Xie Q;Sung JJ;Wat C;Bernaards C;Cui Y;Marcellin P. 

Showing items 26-32 of 32  (2 Page(s) Totally)
<< < 1 2 
View [10|25|50] records per page